SK Chemical and Jeil Health Science Sign OTC Joint Sales Agreement

SK Chemicals' Gineksin F Soft Capsule 120mg and Trust Patch (30P), co-marketed with Jeil Health Science. Photo by SK Chemicals

SK Chemicals announced on the 19th that it has signed a joint sales agreement with Jeil Health Science for certain products of ‘Gineksin’ and ‘Trust’.

The pharmaceuticals covered by the joint sales agreement are ‘Gineksin F Soft Capsules 120mg’ and ‘Trust Patch 30 sheets’. Gineksin is a blood circulation enhancer made from ginkgo leaf extract, and among these, the soft capsule product is exclusively for pharmacies. Trust is sold in packaging units of 7, 10, and 30 sheets, with the ‘Trust Patch 30 sheets’ launched for patients requiring repeated use.

Under this sales agreement, Jeil Health Science will take charge of sales and marketing targeting pharmacies for the two products that were previously distributed through existing pharmaceutical distributors. Jeil Health Science is a general pharmaceutical sales specialist company with a nationwide sales organization and a direct distribution network to over 12,000 pharmacies.

SK Chemicals expects that collaboration with Jeil Health Science will further strengthen the pharmacy sales capabilities of its main general pharmaceutical products, Gineksin and Trust.

Hyunseon Park, Head of SK Chemicals Pharma Business, said, "With joint marketing alongside Jeil Health Science, which has a diverse lineup of patches including Kepentec and Jeil Patch, and the country’s top-level pharmacy network, more aggressive pharmacy marketing has become possible." He added, "We plan to continuously strengthen the position of Gineksin and Trust as leading brands in their respective fields through close cooperation with Jeil Health Science."

Sangcheol Han, CEO of Jeil Health Science, said, “It is very meaningful to be able to collaborate with SK Chemicals in the sales of Gineksin and Trust, which have long been trusted in the fields of blood circulation enhancers and anti-inflammatory and analgesic agents." He added, "Based on Jeil Health Science’s strong sales capabilities, we will do our best to further enhance the market competitiveness of the two products and provide excellent treatment options to more patients.”

This content was produced with the assistance of AI translation services.